Journal of Contemporary Pharmacy

AMMANIF

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Journal of Contemporary Pharmacy is an open-access journal published by AMMANIF in Pakistan, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 500 USD. Declared review time at DOAJ: 26 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
AMMANIF
ISSN
2521-0521
Country
Pakistan
Languages
english
Access
Open access
Declared publication charge
500 USD
Articles in DOAJ
165
Declared review time
26 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2024-08-05
Indexing
DOAJ
APC
500 USD
Declared review time (DOAJ)
26 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2025
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

165

Most recent article

4 months ago

Average review time (journal-declared via DOAJ)

26weeks

Works in OpenAlex

118

Last recorded publication year

2025

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

7

i10-index

5

From OpenAlex open data (CC0).

Editorial & policy10
Last DOAJ review date
2024-08-05
Added to DOAJ
2024-08-05
Declared plagiarism screening
Not declared
Other fees beyond APC
No
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
PKP PN
Editorial board
Official page ↗
Open references deposited at Crossref
59%
ORCID iDs in current deposits
0%
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity1
Source type
journal
Classification2

Subjects (DOAJ)

Medicine: Pharmacy and materia medica

LCC codes

RS1-441

Subject areas

  • Drug Solubulity and Delivery Systems
  • Drug Solubulity and Delivery Systems
  • Advanced Drug Delivery Systems
  • Advanced Drug Delivery Systems
  • Advancements in Transdermal Drug Delivery
  • Advancements in Transdermal Drug Delivery
  • Pharmaceutical studies and practices
  • Pharmaceutical studies and practices
Show all subjects (50)
  • Analytical Methods in Pharmaceuticals
  • Diverse Scientific Research Studies
  • Nanoparticle-Based Drug Delivery
  • Diverse Scientific Research Studies
  • Nanoparticle-Based Drug Delivery
  • Analytical Methods in Pharmaceuticals
  • Pharmaceutical Practices and Patient Outcomes
  • Cancer Treatment and Pharmacology
  • Pharmaceutical Practices and Patient Outcomes
  • Cancer Treatment and Pharmacology
  • biodegradable polymer synthesis and properties
  • biodegradable polymer synthesis and properties
  • Ocular Surface and Contact Lens
  • Toxin Mechanisms and Immunotoxins
  • Cancer Research and Treatment
  • Natural Antidiabetic Agents Studies
  • Ocular Surface and Contact Lens
  • Microencapsulation and Drying Processes
  • Computational Drug Discovery Methods
  • Toxin Mechanisms and Immunotoxins
  • Natural Antidiabetic Agents Studies
  • Cancer Research and Treatment
  • Microencapsulation and Drying Processes
  • Pharmacovigilance and Adverse Drug Reactions
  • Pharmacology and Nanomedicine Research
  • Gastrointestinal motility and disorders
  • Mosquito-borne diseases and control
  • COVID-19 Clinical Research Studies
  • Antibiotic Resistance in Bacteria
  • Epilepsy research and treatment
  • Blood Pressure and Hypertension Studies
  • Liver Disease Diagnosis and Treatment
  • Gastrointestinal motility and disorders
  • Pneumonia and Respiratory Infections
  • Gastroesophageal reflux and treatments
  • Antibiotic Resistance in Bacteria
  • Blood Pressure and Hypertension Studies
  • Epilepsy research and treatment
  • COVID-19 Clinical Research Studies
  • Mosquito-borne diseases and control
  • Liver Disease Diagnosis and Treatment
  • Computational Drug Discovery Methods

Keywords (DOAJ)

  • pharmacy
  • drug discovery
  • drug delivery
  • medical sciences
  • novel drug delivery
  • pharmaceutical sciences

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: